This is a Validated Antibody Database (VAD) review about mouse Ltbr, based on 5 published articles (read how Labome selects the articles), using Ltbr antibody in all methods. It is aimed to help Labome visitors find the most suited Ltbr antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ltbr synonym: AI256028; LTbetaR; Ltar; TNF-R-III; TNFCR; TNFR-RP; TNFR2-RP; TNFRrp; Tnfbr; Tnfrsf3
Knockout validation
Invitrogen rat monoclonal (eBio3C8 (3C8)) |
| Invitrogen Ltbr antibody (eBioscience, 12-5671-82) was used in immunohistochemistry knockout validation on mouse samples (fig 2f) and in flow cytometry on mouse samples (fig 2b, s1c). Cell Rep (2022) ncbi |
Invitrogen
rat monoclonal (eBio3C8 (3C8)) |
| Invitrogen Ltbr antibody (eBioscience, 12-5671-82) was used in immunohistochemistry knockout validation on mouse samples (fig 2f) and in flow cytometry on mouse samples (fig 2b, s1c). Cell Rep (2022) ncbi |
rat monoclonal (eBio3C8 (3C8)) |
| In order to explore the role of adipose-derived mesenchymal stromal cells from dermal white adipose tissue in fibrosis, Invitrogen Ltbr antibody (Affymetrix/eBioscience, eBio3C8) was used in blocking or activating experiments on mouse samples at 1 ug/ml (fig 7c). J Clin Invest (2016) ncbi |
rat monoclonal (eBio3C8 (3C8)) |
| Invitrogen Ltbr antibody (eBioscience, 12-5671) was used in flow cytometry on mouse samples at 2 ug/ml (fig st1). Nat Commun (2016) ncbi |
BioLegend
rat monoclonal (5G11) |
| In order to elucidate the role of Tbet in acute lung injury, BioLegend Ltbr antibody (Biolegend, TG11) was used in flow cytometry on mouse samples (fig 4f). J Leukoc Biol (2017) ncbi |
rat monoclonal (5G11) |
| In order to study the role of ICOS in group 2 innate lymphoid cell responses, BioLegend Ltbr antibody (BioLegend, 5G11) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments